维尔达格利普丁通过自调节促进糖尿病足的愈合
Erik Biros1,2, Venkat Vangaveti3,4, Usman Malabu3,5
1Translational Research in Endocrinology and Diabetes, College of Medicine and Dentistry, James Cook University, 1 James Cook Drive, Townsville, QLD, 4811, Australia. erik.biros@jcu.edu.au.
Diabetology & metabolic syndrome
|August 22, 2024
概括
维尔达格利普丁治疗可以通过减少自,特别是降低NUP62标记物的调节来改善糖尿病足的愈合. 这项研究探讨了接受维尔达格利普丁治疗12周的患者的分子变化.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 内分泌学 在内分泌学.
背景情况:
- 糖尿病足 (DFU) 是糖尿病的一个重要并发症,经常表现出愈合障碍.
- 了解涉及DFU治疗的分子通路对于开发有效治疗非常重要.
研究的目的:
- 调查维尔达利普丁影响糖尿病足愈合的分子机制.
- 评估vildagliptin对与DFU患者的自和亡相关的特定分子标记物的影响.
主要方法:
- 一项涉及患者接受维尔达格利普丁治疗12周的比较研究,与安慰剂组对比.
- 从DFU中收集伤口液体,使用过纸进行RNA提取.
- 定量实时PCR (qPCR) 用于测量自 (NUP62) 和亡 (RIPK3) 标志物的表达水平.
主要成果:
- 与基线相比,维尔达格利普丁治疗在第12周导致了自标志物NUP62的显著下调 (P=0.0234).
- 在安慰剂组中没有观察到NUP62表达的显著变化 (P=0.9102).
- 维尔达格利普丁和安慰剂组都显示了亡标志物RIPK3.3的显著下调.
结论:
- 维尔达格利普丁不仅可以通过控制血糖,还可以通过减少自来促进DFU的愈合.
- 维尔达格利普丁对NUP62的降低调节表明,维尔达格利普丁在调节糖尿病患者的伤口修复中关键的细胞过程中可能具有治疗作用.
相关概念视频
01:23Dipeptidyl Peptidase 4 Inhibitors
179
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
179
01:15Diabetes: Management and Pharmacotherapy
245
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
245